{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:04:22Z","timestamp":1791407062007,"version":"4.3.3"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.bbr.2014.10.025","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T22:33:29Z","timestamp":1414622009000},"page":"176-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":245,"special_numbering":"C","title":["Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents"],"prefix":"10.1016","volume":"285","author":[{"given":"Ben","family":"Grayson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Leger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Harte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna C.","family":"Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.bbr.2014.10.025_bib0005","first-page":"68","article-title":"Novelty and curiosity as determinants of exploratory behvaviour","volume":"41","author":"Berlyne","year":"1950","journal-title":"Br J Psychol"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav Brain Res"},{"issue":"5","key":"10.1016\/j.bbr.2014.10.025_bib0015","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neubiorev.2007.01.005","article-title":"The pharmacology: neuroanatomy and neurogenetics of one-trial object recognition in rodents","volume":"31","author":"Dere","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn Process"},{"issue":"13","key":"10.1016\/j.bbr.2014.10.025_bib0025","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.neuropsychologia.2012.07.034","article-title":"What pharmacological interventions indicate concerning the role of the perirhinal cortex in recognition memory","volume":"50","author":"Brown","year":"2012","journal-title":"Neuropsychologia"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/jmri.22879","article-title":"Left ventricular diastolic function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve","volume":"35","author":"Korosoglou","year":"2012","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00213-011-2536-5","article-title":"Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models","volume":"220","author":"Lyon","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"10.1016\/j.bbr.2014.10.025_bib0040","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1017\/S1461145713000928","article-title":"Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia","volume":"16","author":"Meltzer","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Pt 4","key":"10.1016\/j.bbr.2014.10.025_bib0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1529-8817.2004.00110.x","article-title":"Molecular genetics of late-onset Alzheimer's disease","volume":"68","author":"Kamboh","year":"2004","journal-title":"Ann Hum Genet"},{"issue":"8","key":"10.1016\/j.bbr.2014.10.025_bib0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.arcmed.2012.10.017","article-title":"Genetics of Alzheimer's disease","volume":"43","author":"Alonso Vilatela","year":"2012","journal-title":"Arch Med Res"},{"issue":"Pt 9","key":"10.1016\/j.bbr.2014.10.025_bib0055","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/brain\/awr189","article-title":"The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships","volume":"134","author":"Snowden","year":"2011","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0060","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3233\/JAD-2010-101257","article-title":"Impaired visual recognition memory in amnestic mild cognitive impairment is associated with mesiotemporal metabolic changes on magnetic resonance spectroscopic imaging","volume":"22","author":"Didic","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"5\u20136","key":"10.1016\/j.bbr.2014.10.025_bib0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000347203","article-title":"Impaired visual recognition memory predicts Alzheimer's disease in amnestic mild cognitive impairment","volume":"35","author":"Didic","year":"2013","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1037\/0735-7044.108.1.11","article-title":"Rhinal cortex lesions and object recognition in rats","volume":"108","author":"Mumby","year":"1994","journal-title":"Behav Neurosci"},{"issue":"1-2","key":"10.1016\/j.bbr.2014.10.025_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0166-4328(96)00006-X","article-title":"Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat","volume":"80","author":"Ennaceur","year":"1996","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0080","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00228977","article-title":"Dissociated effects of perirhinal cortex ablation, fornix transection and amygdalectomy: evidence for multiple memory systems in the primate temporal lobe","volume":"99","author":"Gaffan","year":"1994","journal-title":"Exp Brain Res"},{"issue":"12","key":"10.1016\/j.bbr.2014.10.025_bib0085","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1523\/JNEUROSCI.13-12-05418.1993","article-title":"Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys","volume":"13","author":"Meunier","year":"1993","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0090","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/WNL.52.6.1158","article-title":"The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease","volume":"52","author":"Delacourte","year":"1999","journal-title":"Neurology"},{"issue":"Pt 7","key":"10.1016\/j.bbr.2014.10.025_bib0095","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/brain\/awm112","article-title":"3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease","volume":"130","author":"Whitwell","year":"2007","journal-title":"Brain: A J Neurol"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-2012-120151","article-title":"Novel object recognition as a facile behavior test for evaluating drug effects in AbetaPP\/PS1 Alzheimer's disease mouse model","volume":"31","author":"Zhang","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nlm.2010.10.008","article-title":"Ciproxifan: an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease","volume":"95","author":"Bardgett","year":"2011","journal-title":"Neurobiol Learn Mem"},{"issue":"33","key":"10.1016\/j.bbr.2014.10.025_bib0110","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1523\/JNEUROSCI.2884-10.2010","article-title":"A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease","volume":"30","author":"Fukumoto","year":"2010","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.bbadis.2013.02.018","article-title":"Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice","volume":"1832","author":"Gerenu","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.bbr.2014.10.025_bib0120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jnc.12136","article-title":"CHF5074 restores visual memory ability and pre-synaptic cortical acetylcholine release in pre-plaque Tg2576 mice","volume":"124","author":"Giuliani","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2014.10.025_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Martin-Moreno","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"9","key":"10.1016\/j.bbr.2014.10.025_bib0130","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1096\/fj.06-7685com","article-title":"Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model","volume":"21","author":"Mouri","year":"2007","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0135","doi-asserted-by":"crossref","first-page":"e30007","DOI":"10.1371\/journal.pone.0030007","article-title":"Effects of NK-4 in a transgenic mouse model of Alzheimer's disease","volume":"7","author":"Ohta","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/WAD.0b013e3182211ab1","article-title":"Recognition memory and beta-amyloid plaques in adult Tg2576 mice are not modified after oral exposure to aluminum","volume":"26","author":"Ribes","year":"2012","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.bbr.2014.10.025_bib0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-14-44","article-title":"Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice","volume":"14","author":"Sivilia","year":"2013","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbr.2008.12.034","article-title":"Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition","volume":"200","author":"Taglialatela","year":"2009","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.nbd.2009.06.002","article-title":"Effects of voluntary and forced exercise on plaque deposition: hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease","volume":"35","author":"Yuede","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"6815","key":"10.1016\/j.bbr.2014.10.025_bib0160","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/35050103","article-title":"A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease","volume":"408","author":"Chen","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbr.2014.10.025_bib0165","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1037\/0735-7044.113.5.982","article-title":"Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein","volume":"113","author":"Dodart","year":"1999","journal-title":"Behav Neurosci"},{"issue":"9","key":"10.1016\/j.bbr.2014.10.025_bib0170","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1523\/JNEUROSCI.22-09-03445.2002","article-title":"Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice","volume":"22","author":"Dewachter","year":"2002","journal-title":"J Neurosci"},{"issue":"31","key":"10.1016\/j.bbr.2014.10.025_bib0175","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1523\/JNEUROSCI.5721-09.2010","article-title":"Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies","volume":"30","author":"Hillen","year":"2010","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbr.2006.06.034","article-title":"Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside","volume":"173","author":"Zhang","year":"2006","journal-title":"Behav Brain Res"},{"issue":"8","key":"10.1016\/j.bbr.2014.10.025_bib0185","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.neurobiolaging.2007.11.010","article-title":"Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease","volume":"30","author":"Ambree","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.1016\/j.bbr.2014.10.025_bib0190","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/npp.2010.32","article-title":"Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology","volume":"35","author":"Escribano","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0195","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","article-title":"Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease","volume":"19","author":"Greco","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0200","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.5341-09.2010","article-title":"Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein","volume":"30","author":"Harris","year":"2010","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.bbr.2014.10.025_bib0205","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.neurobiolaging.2013.02.015","article-title":"Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model","volume":"34","author":"Knowles","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bbr.2014.10.025_bib0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2013.12.029","article-title":"The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model","volume":"1551","author":"Spilman","year":"2014","journal-title":"Brain Res"},{"issue":"44","key":"10.1016\/j.bbr.2014.10.025_bib0215","doi-asserted-by":"crossref","first-page":"34144","DOI":"10.1074\/jbc.M110.108100","article-title":"ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein\/presenilin 1 mice","volume":"285","author":"Donkin","year":"2010","journal-title":"J Biol Chem"},{"issue":"1-2","key":"10.1016\/j.bbr.2014.10.025_bib0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2004.05.029","article-title":"Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes","volume":"1017","author":"Howlett","year":"2004","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuint.2010.02.001","article-title":"Induced LC degeneration in APP\/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits","volume":"57","author":"Jardanhazi-Kurutz","year":"2010","journal-title":"Neurochem Int"},{"issue":"1-2","key":"10.1016\/j.bbr.2014.10.025_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.11.002","article-title":"Vaccine efficacy of transcutaneous immunization with amyloid beta using a dissolving microneedle array in a mouse model of Alzheimer's disease","volume":"266","author":"Matsuo","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"17","key":"10.1016\/j.bbr.2014.10.025_bib0235","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.bbr.2014.10.025_bib0240","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1074\/jbc.M111.294025","article-title":"Tannic acid is a natural beta-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice","volume":"287","author":"Mori","year":"2012","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.bbr.2014.10.025_bib0245","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/jnr.21713","article-title":"Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging","volume":"86","author":"Scholtzova","year":"2008","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0250","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1248\/bpb.b12-00798","article-title":"Protective effects of ferulic acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease","volume":"36","author":"Yan","year":"2013","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0255","doi-asserted-by":"crossref","first-page":"e16564","DOI":"10.1371\/journal.pone.0016564","article-title":"Orally administrated cinnamon extract reduces beta-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models","volume":"6","author":"Frydman-Marom","year":"2011","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.bbr.2014.10.025_bib0260","doi-asserted-by":"crossref","first-page":"10298","DOI":"10.1074\/jbc.M112.415141","article-title":"beta2 adrenergic receptor: protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models","volume":"288","author":"Wang","year":"2013","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0265","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2012.07.004","article-title":"Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP: PS1, and Mapt (3xTg-AD)","volume":"234","author":"Filali","year":"2012","journal-title":"Behav Brain Res"},{"issue":"10","key":"10.1016\/j.bbr.2014.10.025_bib0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1101\/lm.026070.112","article-title":"Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease","volume":"19","author":"Guzman-Ramos","year":"2012","journal-title":"Learn Mem"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0275","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1471-4159.2011.07532.x","article-title":"A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease","volume":"119","author":"Onishi","year":"2011","journal-title":"J Neurochem"},{"issue":"11","key":"10.1016\/j.bbr.2014.10.025_bib0280","doi-asserted-by":"crossref","first-page":"e27068","DOI":"10.1371\/journal.pone.0027068","article-title":"Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1","volume":"6","author":"Platt","year":"2011","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.bbr.2014.10.025_bib0285","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00018-013-1314-4","article-title":"Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent","volume":"70","author":"Ryan","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"34","key":"10.1016\/j.bbr.2014.10.025_bib0290","doi-asserted-by":"crossref","first-page":"10741","DOI":"10.1523\/JNEUROSCI.1065-09.2009","article-title":"Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology","volume":"29","author":"Polydoro","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2014.10.025_bib0295","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2013.11.046","article-title":"Novel behavioural characteristics of female APPSwe\/PS1DeltaE9 double transgenic mice","volume":"260","author":"Cheng","year":"2014","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0300","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-2012-121543","article-title":"Episodic-like memory for what-where-which occasion is selectively impaired in the 3xTgAD mouse model of Alzheimer's disease","volume":"33","author":"Davis","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.bbr.2014.10.025_bib0305","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","article-title":"Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice","volume":"26","author":"Heneka","year":"2006","journal-title":"J Neurosci"},{"issue":"26","key":"10.1016\/j.bbr.2014.10.025_bib0310","doi-asserted-by":"crossref","first-page":"17941","DOI":"10.1074\/jbc.M601372200","article-title":"Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function","volume":"281","author":"Huang","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0315","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1601-183X.2005.00160.x","article-title":"Progressive cognitive decline in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe","volume":"5","author":"Middei","year":"2006","journal-title":"Genes Brain Behav"},{"issue":"2\u20133","key":"10.1016\/j.bbr.2014.10.025_bib0320","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuropharm.2010.09.002","article-title":"Chronic treatment with the alpha2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APPxPS1 transgenic mice without altering beta-amyloid plaque load or astrocytosis","volume":"60","author":"Scullion","year":"2011","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0325","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1037\/0735-7044.121.6.1180","article-title":"The Swedish mutation of the amyloid precursor protein (APPswe) dissociates components of object-location memory in aged Tg2576 mice","volume":"121","author":"Good","year":"2007","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.bbr.2014.10.025_bib0330","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainresbull.2013.01.011","article-title":"Maladaptive exploratory behavior and neuropathology of the PS-1 P117L Alzheimer transgenic mice","volume":"94","author":"Zufferey","year":"2013","journal-title":"Brain Res Bull"},{"issue":"8","key":"10.1016\/j.bbr.2014.10.025_bib0335","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2174\/138161212799315795","article-title":"The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease","volume":"18","author":"Morley","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0340","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0345","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1254\/jphs.12036FP","article-title":"Effects of ZSET1446\/ST101 on cognitive deficits and amyloid beta deposition in the senescence accelerated prone mouse brain","volume":"119","author":"Yamaguchi","year":"2012","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0350","doi-asserted-by":"crossref","first-page":"e56870","DOI":"10.1371\/journal.pone.0056870","article-title":"Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease","volume":"8","author":"Capurro","year":"2013","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.bbr.2014.10.025_bib0355","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2012.10.033","article-title":"The gamma-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Abeta1-42 seeding and short-term memory deficits in the Abeta25-35 mouse model of Alzheimer's disease","volume":"698","author":"Meunier","year":"2013","journal-title":"Eur J Pharm"},{"issue":"7","key":"10.1016\/j.bbr.2014.10.025_bib0360","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/npp.2012.25","article-title":"Palmitoylethanolamide protects against the amyloid-beta25\u201335-induced learning and memory impairment in mice: an experimental model of Alzheimer disease","volume":"37","author":"D\u2019Agostino","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2014.10.025_bib0365","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxicon.2013.08.059","article-title":"The selective A-type K+ current blocker Tx3-1 isolated from the Phoneutria nigriventer venom enhances memory of naive and Abeta(25\u201335)-treated mice","volume":"76","author":"Gomes","year":"2013","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0370","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neures.2013.08.005","article-title":"Amyloid-\u03b225\u201335 induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2","volume":"77","author":"Isono","year":"2013","journal-title":"Neurosci Res"},{"issue":"7","key":"10.1016\/j.bbr.2014.10.025_bib0375","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1476-5381.2009.00295.x","article-title":"Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice","volume":"157","author":"Lu","year":"2009","journal-title":"Br J Pharm"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0380","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbr.2008.03.002","article-title":"Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25\u201335)","volume":"190","author":"Tsunekawa","year":"2008","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0385","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroscience.2007.04.011","article-title":"Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease","volume":"147","author":"Sipos","year":"2007","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yhbeh.2013.04.009","article-title":"A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer\u2019 disease","volume":"64","author":"He","year":"2013","journal-title":"Horm Behav"},{"issue":"2\u20133","key":"10.1016\/j.bbr.2014.10.025_bib0395","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-2999(97)00128-3","article-title":"Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats","volume":"325","author":"Scali","year":"1997","journal-title":"Eur J Pharm"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0400","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.expneurol.2007.04.007","article-title":"Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil","volume":"206","author":"Luques","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2014.10.025_bib0405","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1741-7015-2-13","article-title":"A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology","volume":"2","author":"McGrath","year":"2004","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0410","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0415","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hup.861","article-title":"Executive function in schizophrenia: what impact do antipsychotics have?","volume":"22","author":"O\u2019Grada","year":"2007","journal-title":"Hum Psychopharmacol"},{"issue":"11","key":"10.1016\/j.bbr.2014.10.025_bib0420","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2165\/00003495-200666110-00004","article-title":"Pharmacological approaches to the management of cognitive dysfunction in schizophrenia","volume":"66","author":"Harvey","year":"2006","journal-title":"Drugs"},{"issue":"213","key":"10.1016\/j.bbr.2014.10.025_bib0425","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-642-25758-2_2","article-title":"Cognitive impairment in schizophrenia","author":"Keefe","year":"2012","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0430","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13651500600969061","article-title":"The influence of neurocognitive dysfunctions on work capacity in schizophrenia patients: a systematic review of the literature","volume":"11","author":"Christensen","year":"2007","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0435","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia?","volume":"153","author":"Green","year":"1996","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.bbr.2014.10.025_bib0440","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2004.06.023","article-title":"Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria","volume":"56","author":"Green","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0445","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/schbul\/sbq106","article-title":"The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy","volume":"36","author":"Moore","year":"2010","journal-title":"Schizophr Bull"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0450","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0455","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0165-5728(87)90055-5","article-title":"Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis. Analysis of basic protein-reactive cells in lymphoid organs and nervous system of donor and recipient animals","volume":"14","author":"Fallis","year":"1987","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0460","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00213-013-3011-2","article-title":"The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats","volume":"228","author":"McIntosh","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.10.025_bib0465","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuropharm.2012.08.014","article-title":"Maternal deprivation effects on brain plasticity and recognition memory in adolescent male and female rats","volume":"68","author":"Marco","year":"2013","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0470","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2005.07.031","article-title":"Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia","volume":"59","author":"Ozawa","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"6123","key":"10.1016\/j.bbr.2014.10.025_bib0475","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1126\/science.1228261","article-title":"Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice","volume":"339","author":"Giovanoli","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbr.2014.10.025_bib0480","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2014.04.005","article-title":"Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation","volume":"40","author":"Giovanoli","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0485","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biopsych.2013.07.011","article-title":"Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems","volume":"75","author":"Meyer","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0490","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.neuropharm.2011.04.025","article-title":"Mouse models of genetic effects on cognition: relevance to schizophrenia","volume":"62","author":"Papaleo","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0495","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1460-9568.2009.07069.x","article-title":"Schizophrenia-related endophenotypes in heterozygous neuregulin-1 \u2018knockout\u2019 mice","volume":"31","author":"O\u2019Tuathaigh","year":"2010","journal-title":"Eur J Neurosci"},{"issue":"10","key":"10.1016\/j.bbr.2014.10.025_bib0500","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/carcin\/11.10.1733","article-title":"Evidence for spontaneous conversion of Mex\u2212 to Mex+ in human lymphoblastoid cells","volume":"11","author":"Arita","year":"1990","journal-title":"Carcinogenesis"},{"issue":"2\u20133","key":"10.1016\/j.bbr.2014.10.025_bib0505","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00213-010-1854-3","article-title":"E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat","volume":"213","author":"Kendall","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0510","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.euroneuro.2010.06.003","article-title":"Activation of alpha7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia","volume":"21","author":"McLean","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2014.10.025_bib0515","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jns.2011.06.054","article-title":"Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES)","volume":"310","author":"Benito-Leon","year":"2011","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0520","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mds.23443","article-title":"Ventricular enlargement and mild cognitive impairment in early Parkinson's disease","volume":"26","author":"Dalaker","year":"2011","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0525","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/j.bbr.2014.10.025_bib0530","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0535","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbr.2012.03.008","article-title":"Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease","volume":"231","author":"Fernandes","year":"2012","journal-title":"Behav Brain Res"},{"issue":"5","key":"10.1016\/j.bbr.2014.10.025_bib0540","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","article-title":"PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease","volume":"144","author":"Shin","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2014.10.025_bib0545","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbr.2013.06.031","article-title":"Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine","volume":"253","author":"Santos","year":"2013","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0550","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.pnpbp.2008.05.004","article-title":"Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson disease","volume":"32","author":"Fernandes","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"Pt 5","key":"10.1016\/j.bbr.2014.10.025_bib0555","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/brain\/awn054","article-title":"Cognitive deficits and striato-frontal dopamine release in Parkinson's disease","volume":"131","author":"Sawamoto","year":"2008","journal-title":"Brain"},{"issue":"20","key":"10.1016\/j.bbr.2014.10.025_bib0560","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1523\/JNEUROSCI.22-20-09099.2002","article-title":"Dopamine modulates the response of the human amygdala: a study in Parkinson's disease","volume":"22","author":"Tessitore","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2014.10.025_bib0565","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.expneurol.2013.01.003","article-title":"The interaction between the dopaminergic forebrain projections and the medial prefrontal cortex is critical for memory of objects: implications for Parkinson's disease","volume":"247","author":"Chao","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2014.10.025_bib0570","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuroscience.2013.09.042","article-title":"Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine","volume":"256","author":"Goes","year":"2014","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.bbr.2014.10.025_bib0575","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2014.10.025_bib0580","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuroscience.2013.11.051","article-title":"Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice","volume":"259","author":"Yabuki","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2014.10.025_bib0585","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbr.2014.04.022","article-title":"Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model","volume":"268","author":"Ho","year":"2014","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0590","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2011.01.028","article-title":"Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia","volume":"219","author":"Ho","year":"2011","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0595","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0600","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ije\/dyt282","article-title":"Maternal lifestyle and environmental risk factors for autism spectrum disorders","volume":"43","author":"Lyall","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1016\/j.bbr.2014.10.025_bib0605","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/jnr.23258","article-title":"REM sleep deprivation generates cognitive and neurochemical disruptions in the intranigral rotenone model of Parkinson's disease","volume":"91","author":"Dos Santos","year":"2013","journal-title":"J Neurosci Res"},{"issue":"8","key":"10.1016\/j.bbr.2014.10.025_bib0610","doi-asserted-by":"crossref","first-page":"e71341","DOI":"10.1371\/journal.pone.0071341","article-title":"Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0615","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1460-9568.2012.08012.x","article-title":"Cognitive deficits in a mouse model of pre-manifest Parkinson's disease","volume":"35","author":"Magen","year":"2012","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0620","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.30081","article-title":"Mouse models of autism spectrum disorders: the challenge for behavioral genetics","volume":"142C","author":"Moy","year":"2006","journal-title":"Am J Med Genet C-Semin Med Genet"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0625","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.rasd.2010.07.007","article-title":"Face memory and object recognition in children with high-functioning autism or Asperger syndrome and in their parents","volume":"5","author":"Kuusikko-Gauffin","year":"2011","journal-title":"Res Autism Spectr Disord"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0630","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/aur.56","article-title":"Specific impairment of face-processing abilities in children with Autism spectrum disorder using the let's face it! skills battery","volume":"1","author":"Wolf","year":"2008","journal-title":"Autism Res"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0635","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2012.07.022","article-title":"Genetic removal of p70 S6 kinase 1 corrects molecular: synaptic, and behavioral phenotypes in fragile X syndrome mice","volume":"76","author":"Bhattacharya","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2014.10.025_bib0640","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuropharm.2012.07.013","article-title":"AMPAKINE enhancement of social interaction in the BTBR mouse model of autism","volume":"64","author":"Silverman","year":"2013","journal-title":"Neuropharmacology"},{"issue":"19","key":"10.1016\/j.bbr.2014.10.025_bib0645","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1523\/JNEUROSCI.6107-11.2012","article-title":"Reduced excitatory neurotransmission and mild Autism-relevant phenotypes in adolescent Shank3 null mutant mice","volume":"32","author":"Yang","year":"2012","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.bbr.2014.10.025_bib0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048975","article-title":"Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to Autism","volume":"7","author":"Kane","year":"2012","journal-title":"PLoS One"},{"issue":"2\u20133","key":"10.1016\/j.bbr.2014.10.025_bib0655","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000341786","article-title":"Effects of rat prenatal exposure to valproic acid on behaviour and neuro-anatomy","volume":"34","author":"Mychasiuk","year":"2012","journal-title":"Dev Neurosci"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0660","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuropharm.2006.09.020","article-title":"Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: implications for an animal model of neurodevelopmental disorders","volume":"52","author":"Presti-Torres","year":"2007","journal-title":"Neuropharmacology"},{"issue":"7530","key":"10.1016\/j.bbr.2014.10.025_bib0665","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.331.7530.1419","article-title":"Long term outcome after traumatic brain injury","volume":"331","author":"Fleminger","year":"2005","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.bbr.2014.10.025_bib0670","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2044.2007.05432.x","article-title":"Determinants of hospital costs associated with traumatic brain injury in England and Wales","volume":"63","author":"Morris","year":"2008","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0675","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/rme.13.41","article-title":"Functional assessment of long-term deficits in rodent models of traumatic brain injury","volume":"8","author":"Gold","year":"2013","journal-title":"Regen Med"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0680","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2013.09.012","article-title":"The effect of NADPH-oxidase inhibitor apocynin on cognitive impairment induced by moderate lateral fluid percussion injury: role of inflammatory and oxidative brain damage","volume":"63","author":"Ferreira","year":"2013","journal-title":"Neurochem Int"},{"issue":"9","key":"10.1016\/j.bbr.2014.10.025_bib0685","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00213-013-3336-x","article-title":"HOE-140: an antagonist of B2 receptor, protects against memory deficits and brain damage induced by moderate lateral fluid percussion injury in mice","volume":"231","author":"Ferreira","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0690","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/neu.2012.2399","article-title":"Repeated mild traumatic brain injury: mechanisms of cerebral vulnerability","volume":"30","author":"Prins","year":"2013","journal-title":"J Neurotrauma"},{"issue":"12","key":"10.1016\/j.bbr.2014.10.025_bib0695","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/jcbfm.2013.144","article-title":"Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury","volume":"33","author":"Zhao","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0700","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2047-9158-3-5","article-title":"The effects of exercise on cognition in Parkinson's disease: a systematic review","volume":"3","author":"Murray","year":"2014","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.bbr.2014.10.025_bib0705","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nbd.2012.12.017","article-title":"Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury","volume":"54","author":"Piao","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.bbr.2014.10.025_bib0710","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nn.3070","article-title":"NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans","volume":"15","author":"Dickendesher","year":"2012","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0715","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/neu.2012.2493","article-title":"Inhibition of Nogo-66 receptor 1 enhances recovery of cognitive function after traumatic brain injury in mice","volume":"30","author":"Tong","year":"2013","journal-title":"J Neurotrauma"},{"issue":"11","key":"10.1016\/j.bbr.2014.10.025_bib0720","doi-asserted-by":"crossref","first-page":"e79837","DOI":"10.1371\/journal.pone.0079837","article-title":"Cognitive impairments accompanying rodent mild traumatic brain injury involve p53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-alpha","volume":"8","author":"Rachmany","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2014.10.025_bib0725","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.brainres.2014.01.044","article-title":"Inosine improves functional recovery after experimental traumatic brain injury","volume":"1555","author":"Dachir","year":"2014","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2014.10.025_bib0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2013.02.006","article-title":"Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury","volume":"54","author":"Tweedie","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0735","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/neu.1994.11.187","article-title":"The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury","volume":"11","author":"Hamm","year":"1994","journal-title":"J Neurotrauma"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0740","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/neu.1997.14.99","article-title":"Motor and cognitive functional deficits following diffuse traumatic brain injury in the immature rat","volume":"14","author":"Adelson","year":"1997","journal-title":"J Neurotrauma"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0745","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11912-013-0307-7","article-title":"Clearing the air: a review of our current understanding of chemo fog","volume":"15","author":"O\u2019Farrell","year":"2013","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0750","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","article-title":"Chemotherapy-related cognitive dysfunction","volume":"12","author":"Wefel","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"10.1016\/j.bbr.2014.10.025_bib0755","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/17425240903167942","article-title":"New strategies to deliver anticancer drugs to brain tumors","volume":"6","author":"Laquintana","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0760","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/09540261.2013.864260","article-title":"Prevalence: mechanisms, and management of cancer-related cognitive impairment","volume":"26","author":"Janelsins","year":"2014","journal-title":"Int Rev Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2014.10.025_bib0765","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11682-013-9228-1","article-title":"Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy","volume":"7","author":"Kesler","year":"2013","journal-title":"Brain Imaging Behav"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0770","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/hbm.21033","article-title":"Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients","volume":"32","author":"Deprez","year":"2011","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0775","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10549-006-9380-z","article-title":"Altered frontocortical: cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5\u201310 years after chemotherapy","volume":"103","author":"Silverman","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.bbr.2014.10.025_bib0780","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.critrevonc.2007.06.001","article-title":"Cognitive function after chemotherapy in adults with solid tumours","volume":"63","author":"Vardy","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"10.1016\/j.bbr.2014.10.025_bib0785","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1158\/1078-0432.CCR-12-3764","article-title":"Effects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivors","volume":"19","author":"Bisen-Hersh","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.bbr.2014.10.025_bib0790","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bbr.2014.10.025_bib0795","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-013-3301-8","article-title":"The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice","volume":"231","author":"Fardell","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0800","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00213-011-2466-2","article-title":"Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity","volume":"220","author":"Fardell","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.bbr.2014.10.025_bib0805","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbi.2010.02.004","article-title":"Mammary tumors induce select cognitive impairments","volume":"24","author":"Pyter","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0810","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbr.2010.01.016","article-title":"The chemotherapy agent: thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors in mice","volume":"209","author":"Mondie","year":"2010","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0815","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroscience.2008.08.060","article-title":"A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice","volume":"157","author":"Gandal","year":"2008","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bbr.2014.10.025_bib0820","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbr.2009.11.017","article-title":"Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil","volume":"208","author":"ElBeltagy","year":"2010","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.bbr.2014.10.025_bib0825","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2007.08.004","article-title":"Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat","volume":"186","author":"Seigers","year":"2008","journal-title":"Behav Brain Res"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814006901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814006901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T20:10:33Z","timestamp":1565986233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432814006901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":165,"alternative-id":["S0166432814006901"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2014.10.025","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2014.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}